OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
October 11, 2006
Drug giant beefs up early-stage R&D, moving into Genentech's turf.
JAMA study questions effectiveness of popular antidepressants.
After axing oncology, Gilead says it's ready for new therapeutic areas.